Loomis Sayles & CO L P Gsk PLC Transaction History

Loomis Sayles & CO L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$39.75 - $42.69 $823,262 - $884,152	-20,711 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $343,299 - $370,600	-8,667 Reduced 29.5%	20,711 $835,000
Q1 2018 May 11, 2018	SELL	$36.18 - $40.15 $22,612 - $25,093	-625 Reduced 2.08%	29,378 $1.15 Million
Q2 2017 Aug 14, 2017	BUY	N/A	30,003	30,003 $1.29 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.1B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.